David L Sloman
6PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Apr 09, 2026
From KRASG12D to Pan-KRAS Inhibitors─A Journey Enabled by Synthetic Innovation and Structure-Based Drug Design.Xiaoshen Ma, David L Sloman, Timothy J Henderson
|Jun 26, 2024
Discovery of MK-1084: An Orally Bioavailable and Low-Dose KRASG12C Inhibitor.Xiaoshen Ma, David L Sloman, Ruchia Duggal
|Apr 18, 2024
Unexpected Noncovalent Off-Target Activity of Clinical BTK Inhibitors Leads to Discovery of a Dual NUDT5/14 Antagonist.Esra Balıkçı, Anne-Sophie M C Marques, Ludwig G Bauer
|Apr 22, 2022
Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors.Chunhui Huang, Christian Fischer, Michelle R Machacek
|Mar 03, 2022
Oxetane Promise Delivered: Discovery of Long-Acting IDO1 Inhibitors Suitable for Q3W Oral or Parenteral Dosing.Derun Li, David L Sloman, Abdelghani Achab
|Nov 19, 2021
Comprehensive Strategies to Bicyclic Prolines: Applications in the Synthesis of Potent Arginase Inhibitors.Derun Li, Hongjun Zhang, Thomas W Lyons
Pageof 1
Frequent Collaborators
3 joint publications
Yongxin Han
2 joint publications
Hongjun Zhang
2 joint publications
Thomas W Lyons
2 joint publications
Qinglin Pu
2 joint publications
Erik V Munsell
2 joint publications
Theodore A Martinot
2 joint publications
Xiaoshen Ma
2 joint publications
Charles A Lesburg
2 joint publications
Catherine White
2 joint publications
Xavier Fradera
